Bosutinib Suppliers & Bulk Manufacturers

Available Forms: Tablets

Available Strengths: 100 mg, 400 mg, 500 mg

Reference Brands: Bosulif (USA)

Category: Oncology Cancer Care

Bosutinib is an oral tyrosine kinase inhibitor (TKI) used for the treatment of Philadelphia chromosome–positive chronic myeloid leukemia (Ph+ CML). It works by blocking the BCR-ABL kinase enzyme that promotes the growth of cancerous white blood cells. Marketed under the brand name Bosulif, it is available as film-coated tablets in 100 mg, 400 mg, and 500 mg strengths. It is indicated for patients who are newly diagnosed or resistant/intolerant to prior TKI therapy. Bosutinib is available in Tablets and strengths such as 100 mg, 400 mg, 500 mg. Sourced from GMP-certified and ISO-compliant manufacturers, this API meets global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical formulation and commercial manufacturing, Bosutinib is supplied in bulk quantities with complete regulatory support including DMF, COA, and MSDS.

Bosutinib can be exported to over 30 countries across Asia, Africa, Europe, and Latin America. Flexible packaging, competitive pricing, and a verified supplier network make Pharmatradz a trusted sourcing partner for pharmaceutical companies and contract manufacturers worldwide.